UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis

Alimentary pharmacology & therapeutics, 2006-06, Vol.23 (11), p.1567-1574

2006

Volltextzugriff (PDF)

Methodology and Indications of H2‐Breath Testing in Gastrointestinal Diseases: the Rome Consensus Conference

Alimentary pharmacology & therapeutics, 2009-03, Vol.29, p.1-49

2009

Volltextzugriff (PDF)

Editorial - COVID-19 and the microbiota: new kids on the block

European review for medical and pharmacological sciences, 2020-05, Vol.24 (9), p.5189

2020

Volltextzugriff (PDF)

Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study

The Lancet (British edition), 2007-12, Vol.370 (9603), p.1915-1922

2007

Volltextzugriff (PDF)

Clinical trial: the effects of a probiotic mixture on non‐steroidal anti‐inflammatory drug enteropathy – a randomized, double‐blind, cross‐over, placebo‐controlled study

Alimentary pharmacology & therapeutics, 2010-07, Vol.32 (2), p.209-214

2010

Volltextzugriff (PDF)

Editorial - COVID-19 pandemic outbreak and the Latin rule of Bernard de Clairvaux. Have we forgotten the past?

European review for medical and pharmacological sciences, 2020-06, Vol.24 (12), p.7194

2020

Volltextzugriff (PDF)

Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case–control study in irritable bowel syndrome

Alimentary pharmacology & therapeutics, 2005-12, Vol.22 (11‐12), p.1157-1160

2005

Volltextzugriff (PDF)

High dosage rifaximin for the treatment of small intestinal bacterial overgrowth

Alimentary Pharmacology and Therapeutics, 2007-04, Vol.25 (7), p.781-786

2007

Volltextzugriff (PDF)

High efficacy of 1‐week doxycycline‐ and amoxicillin‐based quadruple regimen in a culture‐guided, third‐line treatment approach for Helicobacter pylori infection

Alimentary pharmacology & therapeutics, 2004-04, Vol.19 (7), p.789-795

2004

Volltextzugriff (PDF)

Bacillus clausii therapy to reduce side‐effects of anti‐Helicobacter pylori treatment: randomized, double‐blind, placebo controlled trial

Alimentary pharmacology & therapeutics, 2004-11, Vol.20 (10), p.1181-1188

2004

Volltextzugriff (PDF)

Low‐dose lactose in drugs neither increases breath hydrogen excretion nor causes gastrointestinal symptoms

Alimentary pharmacology & therapeutics, 2008-10, Vol.28 (8), p.1003-1012

2008

Volltextzugriff (PDF)

Meta‐analysis: the effect of probiotic administration on antibiotic‐associated diarrhoea

Alimentary pharmacology & therapeutics, 2002-08, Vol.16 (8), p.1461-1467

2002

Volltextzugriff (PDF)

The effect of oral administration of Lactobacillus GG on antibiotic‐associated gastrointestinal side‐effects during Helicobacter pylori eradication therapy

Alimentary pharmacology & therapeutics, 2001-02, Vol.15 (2), p.163-169

2001

Volltextzugriff (PDF)

Rifaximin dose‐finding study for the treatment of small intestinal bacterial overgrowth

Alimentary pharmacology & therapeutics, 2005-07, Vol.22 (1), p.31-35

2005

Volltextzugriff (PDF)

Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER Study

Gut, 2007-04, Vol.56 (4), p.475-479

2007

Volltextzugriff (PDF)

Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth

Alimentary pharmacology & therapeutics, 2005-06, Vol.21 (11), p.1391-1395

2005

Volltextzugriff (PDF)

Oral desensitizing treatment in food allergy: clinical and immunological results

Alimentary pharmacology & therapeutics, 2003-02, Vol.17 (3), p.459-465

2003

Volltextzugriff (PDF)

A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates

Alimentary pharmacology & therapeutics, 2000-12, Vol.14 (12), p.1625-1629

2000

Volltextzugriff (PDF)

Bacteroides thetaiotaomicron in the gut: Molecular aspects of their interaction

Digestive and liver disease, 2007-08, Vol.39 (8), p.707-712

2007

Volltextzugriff (PDF)

Cutaneous manifestations in celiac disease

World journal of gastroenterology : WJG, 2006-02, Vol.12 (6), p.843

2006

Volltextzugriff (PDF)

“Cervia II Working Group Report 2006”: Guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy

Digestive and liver disease, 2007-08, Vol.39 (8), p.782-789

2007

Volltextzugriff (PDF)

P.02.13: Can Gender Affect Dob Values Obtained by 13-C Urea Breath Test?

Digestive and liver disease, 2017-03, Vol.49, p.e142-e143

2017

Volltextzugriff (PDF)

Efficacy of two one‐week rabeprazole/levofloxacin‐based triple therapies for Helicobacter pylori infection

Alimentary pharmacology & therapeutics, 2000-10, Vol.14 (10), p.1339-1343

2000

Volltextzugriff (PDF)

Levofloxacin‐based triple therapy vs. quadruple therapy in second‐line Helicobacter pylori treatment: a randomized trial

Alimentary pharmacology & therapeutics, 2003-09, Vol.18 (6), p.627-633

2003

Volltextzugriff (PDF)

Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis

Digestive and liver disease, 2007-09, Vol.39 (9), p.878-882

2007

Volltextzugriff (PDF)

1 – 25 von 2.080

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.829)
Mit Volltextzugriff
(1.481)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(1.103)
Science & Technology
(937)
Life Sciences & Biomedicine
(930)
Male
(642)
Female
(617)
Adult
(560)
Middle Aged
(499)
Biological And Medical Sciences
(489)
Medical Sciences
(480)
Gastroenterology & Hepatology
(464)
Aged
(293)
Gastroenterology And Hepatology
(287)
Gastroenterology. Liver. Pancreas. Abdomen
(198)
Pharmacology & Pharmacy
(192)
Other Diseases. Semiology
(147)
Adolescent
(139)
Helicobacter Pylori
(137)
Pharmacology. Drug Treatments
(115)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(104)
Treatment Outcome
(94)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis

Methodology and Indications of H2‐Breath Testing in Gastrointestinal Diseases: the Rome Consensus Conference

Editorial - COVID-19 and the microbiota: new kids on the block

Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study

Clinical trial: the effects of a probiotic mixture on non‐steroidal anti‐inflammatory drug enteropathy – a randomized, double‐blind, cross‐over, placebo‐controlled study

Editorial - COVID-19 pandemic outbreak and the Latin rule of Bernard de Clairvaux. Have we forgotten the past?

Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case–control study in irritable bowel syndrome

High dosage rifaximin for the treatment of small intestinal bacterial overgrowth

High efficacy of 1‐week doxycycline‐ and amoxicillin‐based quadruple regimen in a culture‐guided, third‐line treatment approach for Helicobacter pylori infection

Bacillus clausii therapy to reduce side‐effects of anti‐Helicobacter pylori treatment: randomized, double‐blind, placebo controlled trial

Low‐dose lactose in drugs neither increases breath hydrogen excretion nor causes gastrointestinal symptoms

Meta‐analysis: the effect of probiotic administration on antibiotic‐associated diarrhoea

The effect of oral administration of Lactobacillus GG on antibiotic‐associated gastrointestinal side‐effects during Helicobacter pylori eradication therapy

Rifaximin dose‐finding study for the treatment of small intestinal bacterial overgrowth

Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER Study

Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth

Oral desensitizing treatment in food allergy: clinical and immunological results

A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates

Bacteroides thetaiotaomicron in the gut: Molecular aspects of their interaction

Cutaneous manifestations in celiac disease

“Cervia II Working Group Report 2006”: Guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy

P.02.13: Can Gender Affect Dob Values Obtained by 13-C Urea Breath Test?

Efficacy of two one‐week rabeprazole/levofloxacin‐based triple therapies for Helicobacter pylori infection

Levofloxacin‐based triple therapy vs. quadruple therapy in second‐line Helicobacter pylori treatment: a randomized trial

Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis

Suchergebnisse filtern